Optimal allocation of resources over health care programmes: Dealing with decreasing marginal utility and uncertainty

Health Economics

Volumn 14, Issue 7, 2005, Pages 655-667

  Al, Maiwenn J ^a   Feenstra, Talitha L ^b   van Hout, Ben A ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Allocation; Budget restrictions; Decision rules; Economic evaluation; Uncertainty

Indexed keywords

ANTILIPEMIC AGENT;

ARTICLE; BUDGET; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH ECONOMICS; HEALTH PROGRAM; MATHEMATICAL COMPUTING; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RESOURCE ALLOCATION; RISK ASSESSMENT; THEORETICAL STUDY;

BUDGETS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEALTH CARE COSTS; HEALTH CARE RATIONING; HEALTH SERVICES; HEALTH SERVICES RESEARCH; MODELS, ECONOMIC; UNCERTAINTY;

EID: 21844462826     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.973     Document Type: Article

References (25)

1. Weinstein M, Zeckhauser R. Critical ratios and efficient allocation. J Public Econ 1973; 2: 147-157.
2. Gafni A, Birch S. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Can Med Assoc J 1993; 148: 913-917.
3. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programmes. Health Serv Res 1972; 7: 118-133.
4. Hutubessy RW, Evans DB, Barendregt JJ et al. Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Econ 2001; 10: 473-477.
5. Meltzer D. Addressing uncertainty in medical cost-effectiveness analysis. Implications of expected utility maximazation for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research. J Health Econ 2001; 20: 109-129.
6. O'Brien BJ, Sculpher MJ. Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules. Med Care 2000; 38: 460-468.
7. Stinnett AA, Paltiel AD. Mathematical programming for the efficient allocation of health care resources. J Health Econ 1996; 15: 641-653.
8. Laska EM, Meisner M, Siegel C. Statistical inference for cost-effectiveness ratios. Health Econ 1997; 6: 229-242.
9. Birch S, Donaldson C. Applications of cost-benefit analysis to health care: departures from welfare economic theory. J Health Econ 1987; 6: 211-225.
10. Sugden R, Williams A. The Principles of Practical Cost-Benefit Analysis. Oxford University Press: Oxford, 1978.
11. Centraal begeleidingsorgaan voor de intercollegiale toetsing. Behandeling en preventie van coronaire hartziekte door verlaging van de plasmacholesterol-concentratie, Centraal begeleidingsorgaan voor de intercollegiale toetsing: Utrecht, 1998.
12. Niessen LW, Dippel DWJ, Limburg M. Berekening van kosten na beroerte en kosteneffectiviteit van 'stroke units' en van secundaire preventie, zoals aanbevolen in de herziene CBO-richtlijn 'Beroerte' [Calculation of costs and cost effectiveness of stroke units and of secundary prevention in patients after a stroke, as recommended in the revised CBO guideline 'Stroke']. Nederlands Tijdschrift voor Geneeskunde 2000; 144: 1959-1964.
13. Health WCoMA. Macroeconomics and health: investing in health for economic development. Report of the Commision on Macroeconomics. World Health Organization: Geneva, 2001.
14. Keeney RL, Raiffa H. Decisions with Multiple Objectives. Cambridge University Press: Cambridge, 1993.
15. Varian HR. Microeconomic Analysis (2nd edn). W.W. Norton & Company: New York, 1984.
16. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999; 18: 341-364.
17. Arrow K, Lind A. Uncertainty and the evaluation of public investment decisions. Am Econ Rev 1970; 60: 364-378.
18. Ben-Zion U, Gafni A. Evaluation of public investment in health care: is the risk relevant? J Health Econ 1983; 2: 161-165.
19. Graff Zivin J. Cost-effectiveness analysis with risk aversion. Health Econ 2001; 10: 499-508.
20. Graff Zivin J, Bridges J. Addressing risk preferences in cost-effectiveness analyses. Appl Health Econ Health Policy 2002; 1(3): 135-139.
21. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios:an example from a randomized trial. Stat Med 1996; 15: 1447-1458.
22. van Hout BA, Al MJ, Gordon GS et al. Costs, effects and c/e-ratios alongside a clinical trial. Health Econ 1994; 3: 309-319.
23. Fieller EC. Some problems in interval estimation. J Roy Stat Soc Ser B 1954; 16: 175-185.
24. McGuire A. Theoretical concepts in the economic evaluation of health care. In Economic Evaluation in Health Care, Drummond M, McGuire A (eds). Oxford University Press: Oxford, 2001.
25. Tsuchiya A, Williams A. Welfare economics and economic evaluation. In Economic Evaluation in Health Care; Merging Theory with Practice, Drummond M, McGuire A (eds). Oxford University Press: Oxford, 2001.